PaxMedica, Inc. Common Stock (PXMD)

USD 0.0

(0.0%)

Revenue Summary of PaxMedica, Inc. Common Stock

  • PaxMedica, Inc. Common Stock's latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • PaxMedica, Inc. Common Stock's latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • PaxMedica, Inc. Common Stock reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • PaxMedica, Inc. Common Stock reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • PaxMedica, Inc. Common Stock reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • PaxMedica, Inc. Common Stock reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of PaxMedica, Inc. Common Stock (2023 - 2019)

Historical Annual Revenue of PaxMedica, Inc. Common Stock (2023 - 2019)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of PaxMedica, Inc. Common Stock

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Aridis Pharmaceuticals, Inc. - USD NaN%
Biora Therapeutics, Inc. 4000.00 USD 100.0%
Bio-Path Holdings, Inc. - USD NaN%
Better Therapeutics, Inc. - USD NaN%
Calithera Biosciences, Inc. - USD NaN%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
eFFECTOR Therapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. - USD NaN%
Evelo Biosciences, Inc. - USD NaN%
Evolutionary Genomics, Inc. - USD NaN%
Finch Therapeutics Group, Inc. 107 Thousand USD 100.0%
Galera Therapeutics, Inc. - USD NaN%
Innovation1 Biotech Inc. - USD NaN%
Kiromic BioPharma, Inc. - USD NaN%
Molecular Templates, Inc. 57.3 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NexImmune, Inc. - USD NaN%
Orgenesis Inc. 530 Thousand USD 100.0%
Panbela Therapeutics, Inc. - USD NaN%
Point of Care Nano-Technology, Inc. - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 62.83 Million USD 100.0%
Statera Biopharma, Inc. - USD NaN%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 100.0%
Trevena, Inc. 3.12 Million USD 100.0%
Vaxxinity, Inc. - USD NaN%
Vaccinex, Inc. 570 Thousand USD 100.0%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. - USD NaN%
ZIVO Bioscience, Inc. 27.65 Thousand USD 100.0%